Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang-Xin Fu

Showing results (321-330 of 337) with videos related to

Pageof 34
Sort By:
BMC Cancer|September 3, 2014
Intratumoral heterogeneity impacts the response to anti-neu antibody therapyHyunkeun Song, Tae Oh Kim, Sun Young Ma, et al.
The Journal of Experimental Medicine|October 7, 2025
Tumors with microsatellite instability upregulate TREX1 to escape antitumor immunityYan Xu, Zheqi Zhou, Wenzheng Chen, et al.
Cell Reports|February 27, 2020
Gliomas Interact with Non-glioma Brain Cells via Extracellular VesiclesXiaofei Gao, Zhaohuan Zhang, Tomoyuki Mashimo, et al.
The Journal of Experimental Medicine|January 14, 2009
Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- miceRolf Gräbner, Katharina Lötzer, Sandra Döpping, et al.
Science Translational Medicine|February 25, 2021
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunityYuzhu Hou, Hua L Liang, Xinshuang Yu, et al.
The Journal of Clinical Investigation|May 20, 2014
Targeting CD137 enhances the efficacy of cetuximabHolbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.
The Journal of Clinical Investigation|June 4, 2019
Targeting CD137 enhances the efficacy of cetuximabHolbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.
Cell Research|July 16, 2021
Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2Shiyu Sun, Yueqi Cai, Tian-Zhang Song, et al.
Nature Cancer|September 28, 2020
eIF5B drives integrated stress response-dependent translation of PD-L1 in lung cancerShruthy Suresh, BeiBei Chen, Jingfei Zhu, et al.
Cancer Cell|December 18, 2020
DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor ImmunityChangzheng Lu, Junhong Guan, Steve Lu, et al.
Pageof 34

Showing results (321-330 of 337) with videos related to

Sort By:
Pageof 34
BMC Cancer|September 3, 2014
Intratumoral heterogeneity impacts the response to anti-neu antibody therapyHyunkeun Song, Tae Oh Kim, Sun Young Ma, et al.
The Journal of Experimental Medicine|October 7, 2025
Tumors with microsatellite instability upregulate TREX1 to escape antitumor immunityYan Xu, Zheqi Zhou, Wenzheng Chen, et al.
Cell Reports|February 27, 2020
Gliomas Interact with Non-glioma Brain Cells via Extracellular VesiclesXiaofei Gao, Zhaohuan Zhang, Tomoyuki Mashimo, et al.
The Journal of Experimental Medicine|January 14, 2009
Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- miceRolf Gräbner, Katharina Lötzer, Sandra Döpping, et al.
Science Translational Medicine|February 25, 2021
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunityYuzhu Hou, Hua L Liang, Xinshuang Yu, et al.
The Journal of Clinical Investigation|May 20, 2014
Targeting CD137 enhances the efficacy of cetuximabHolbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.
The Journal of Clinical Investigation|June 4, 2019
Targeting CD137 enhances the efficacy of cetuximabHolbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.
Cell Research|July 16, 2021
Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2Shiyu Sun, Yueqi Cai, Tian-Zhang Song, et al.
Nature Cancer|September 28, 2020
eIF5B drives integrated stress response-dependent translation of PD-L1 in lung cancerShruthy Suresh, BeiBei Chen, Jingfei Zhu, et al.
Cancer Cell|December 18, 2020
DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor ImmunityChangzheng Lu, Junhong Guan, Steve Lu, et al.
Pageof 34